TMB, CIS, and MATH scores help to evaluate intratumor genetic heterogeneity, which is closely related to drug resistance and poor outcomes in patients with lung cancer harboring EGFR mutations.28, 29, 30, 31, 32, 33. This evidence concerns the gene EGFR and in situ carcinoma.